Circuitous Path to Live Donor Liver Transplantation from the Coordinator's Perspective

The process of live donor liver transplantation is complex and involves multiple stages of coordination. Prior research has explored the medical and logistical challenges of organ transplantation, but gaps remain in understanding the timeline and risk factors for interruptions in live donor cases. This uncertainty drives the need for a detailed analysis of the LDLT process from the coordinator's perspective. The current literature lacks a comprehensive view of the time intervals and barriers that affect LDLT outcomes. While some studies have examined donor and recipient health factors, none have focused on the full sequence of events from listing to transplantation. This gap motivated the current study to investigate the time points and risk factors associated with LDLT implementation. Understanding these factors may help improve coordination and reduce delays. The literature does not fully address the role of donor motivation and recipient stability in the LDLT process. This study aims to fill that gap by analyzing the timeline and root causes of LDLT interruptions.

The goal of this study was to analyze the LDLT process from the coordinator's viewpoint. Specifically, the researchers aimed to determine the time intervals and risk factors that affect LDLT implementation. They focused on hospitalized patients who were wait-listed and had potential live donors. The study sought to identify the time from wait-listing to donor appearance and from donor appearance to transplantation. It also aimed to explore the root causes of LDLT failure. The researchers wanted to understand how medical conditions and donor-related factors influence the likelihood of LDLT. They hypothesized that certain recipient and donor characteristics might predict LDLT success or failure. By examining these factors, the study aimed to provide insights into improving the LDLT process.

This study used a retrospective single-center design to analyze medical records of wait-listed patients and potential live donors. The researchers reviewed data from patients who were hospitalized and had potential live donors. They focused on key time points in the LDLT process, including the appearance of a potential donor and the eventual transplantation. The study also examined the reasons why LDLT was not implemented for some patients. The researchers collected data on recipient and donor characteristics, including medical conditions and donor motivation. They used statistical methods to assess the association between these factors and LDLT outcomes. The analysis included both adult and pediatric patients to capture a broad perspective. The study design allowed for a systematic evaluation of the LDLT timeline and barriers.

The study included 417 patients, with 331 completing the live donor evaluation process. Of these, 205 received LDLT, and 126 did not. The median time from wait-listing to donor appearance was 19.0 days, with an interquartile range of 4.0 to 58.0 days. The median time from donor appearance to transplantation or deceased donor liver transplantation was 68.0 days, with an interquartile range of 28.0 to 188.0 days. The 1-year mortality rate for patients on the waiting list was 34.3%. Risk factors for not implementing LDLT included hepatitis B virus, encephalopathy, and hypertension. Increased total bilirubin levels were also associated with LDLT failure. Biliary atresia was a positive predictor of LDLT. The main barriers to LDLT were the recipient's critical illness, donor physical conditions, and donor motivation. These findings suggest that medical and logistical factors significantly affect LDLT outcomes.

The study found that having a potential live donor does not guarantee that a patient will receive LDLT. The process is time-consuming and subject to multiple interruptions. The most common reason for LDLT failure was the recipient's critical illness. Other barriers included donor physical conditions and motivation. The researchers propose that aggressive medical support and tailored management policies may help reduce the loss of transplantable patients during the LDLT process. The study highlights the importance of addressing both recipient and donor factors in LDLT planning. The findings suggest that improving donor motivation and recipient stability could enhance LDLT success rates. The authors emphasize the need for better coordination and support for both patients and donors. These insights may inform future strategies to optimize the LDLT process.